SCHEMBL3665561

SCHEMBL3665561

CCCCOC(=O)c1ccccc1-c1ccc(Cn2c(OCC)nc(CC)c2C=NO)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.45
MME P08473 3/20 0.45
AGTR2 P50052 2/20 0.42
PPARG P37231 2/20 0.42
ABCB11 O95342 1/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2C9 P11712 1/20 0.42
ADRB3 P13945 1/20 0.42
ADRA2B P18089 1/20 0.42
SLC6A2 P23975 1/20 0.42
TBXAS1 P24557 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
PDE3A Q14432 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1256471 0.86 AGTR1 (0.46) AGTR1MMEAGTR2PPARGABCB11
SCHEMBL1256473 0.86 AGTR1 (0.46) AGTR1MMEAGTR2PPARGABCB11
SCHEMBL3665032 0.81 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL3663040 0.77 AGTR1 (0.41) AGTR1MMEAGTR2LTB4R2
SCHEMBL1257867 0.75 ACHE (0.45) AGTR1MMEAGTR2PPARGABCB11
SCHEMBL1257865 0.75 ACHE (0.45) AGTR1MMEAGTR2PPARGABCB11
SCHEMBL16290091 0.75 AGTR1 (0.49) AGTR1MMEAGTR2PPARGABCB11
SCHEMBL1258934 0.74 AGTR1 (0.49) AGTR1MMEAGTR2
SCHEMBL19596566 0.74 AGTR1 (0.49) AGTR1MMEAGTR2
SCHEMBL1108609 0.74 AGTR1 (0.49) AGTR1MMEAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146963-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2010-01-27 EP disclosed
WO-2008133896-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2008-11-06 WO disclosed